ZOETIS INC.

XNYSHealth care

Last traded price · USD

$83.49

+0.60%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:14 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $82.99
Volume: 2,311
Day's high: —
Day's low: —

In brief

ZOETIS INC. is a health care company listed on the New York Stock Exchange, valued at about $34.50B.
Its shares closed at $82.99 on 3 Nov 2026, down 42.5% over the past year.
From India you can buy ZTS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ZOETIS INC. (ZTS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole ZTS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade ZTS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +16.2% (SPY −2.6%, XLV +9.9%). 3 months: +9.1% (SPY −2.2%, XLV +13.5%). 1 year: −42.5% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ZTS, SPY and XLV · as of 3 Nov 2026
Above its 50-day average, below its 200-day
The 3 Nov 2026 close of $82.99 was 10.3% above its 50-day average ($75.27) and 10.9% below its 200-day average ($93.11). It has closed below the 200-day for 472 sessions, since 16 Dec 2024. The 50-day average crossed below the 200-day on 30 Dec 2024, 462 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
22% of the way up its 52-week range
Closed at $82.99 on 3 Nov 2026: 37.4% below the 52-week high of $132.49 (12 Feb 2026) and 20.7% above the low of $68.77 (2 Oct 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Short interest at 4.2% of shares outstanding
17.5M shares were sold short at the 15 Oct 2026 settlement, 4.2% of the 413.2M shares outstanding; covering them would take 4.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+16.2%

6 months−26.3%

1 year−42.5%

5 years−60.7%

Newswire

About

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Website

Notable moves

May 7, 2026
−21.50%
November 4, 2025
−13.78%
November 3, 2022
−11.01%

ZOETIS INC.

XNYSHealth care

Last traded price · USD

$83.49

+0.60%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:14 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $82.99
Volume: 2,311
Day's high: —
Day's low: —

In brief

ZOETIS INC. is a health care company listed on the New York Stock Exchange, valued at about $34.50B.
Its shares closed at $82.99 on 3 Nov 2026, down 42.5% over the past year.
From India you can buy ZTS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ZOETIS INC. (ZTS) shares from India?

Do I need the price of a whole ZTS share to invest?

How much can I invest in US stocks in a year?

Can I trade ZTS options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +16.2% (SPY −2.6%, XLV +9.9%). 3 months: +9.1% (SPY −2.2%, XLV +13.5%). 1 year: −42.5% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ZTS, SPY and XLV · as of 3 Nov 2026
Above its 50-day average, below its 200-day
The 3 Nov 2026 close of $82.99 was 10.3% above its 50-day average ($75.27) and 10.9% below its 200-day average ($93.11). It has closed below the 200-day for 472 sessions, since 16 Dec 2024. The 50-day average crossed below the 200-day on 30 Dec 2024, 462 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
22% of the way up its 52-week range
Closed at $82.99 on 3 Nov 2026: 37.4% below the 52-week high of $132.49 (12 Feb 2026) and 20.7% above the low of $68.77 (2 Oct 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Short interest at 4.2% of shares outstanding
17.5M shares were sold short at the 15 Oct 2026 settlement, 4.2% of the 413.2M shares outstanding; covering them would take 4.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+16.2%

6 months−26.3%

1 year−42.5%

5 years−60.7%

Newswire

About

Website

Notable moves

May 7, 2026
−21.50%
November 4, 2025
−13.78%
November 3, 2022
−11.01%

ZOETIS INC.

ZOETIS INC. in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50-day average, below its 200-day

22% of the way up its 52-week range

Short interest at 4.2% of shares outstanding

ZOETIS INC.

ZOETIS INC. in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50-day average, below its 200-day

22% of the way up its 52-week range

Short interest at 4.2% of shares outstanding